Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12

J Neurol Sci. 2011 Jun 15;305(1-2):75-9. doi: 10.1016/j.jns.2011.03.008. Epub 2011 Apr 6.

Abstract

Objective: One primary assumption underlying the unambiguous interpretation of change in Multiple Sclerosis Walking Scale-12 (MSWS-12) scores over time is longitudinal measurement invariance (i.e., Is the same construct being measured over time?). Such an assumption was tested in the present study over periods of 6 and 12 months in persons with relapsing-remitting multiple sclerosis (RRMS).

Method: Participants completed a battery of questionnaires that included the MSWS-12 at baseline (n=269) and 6-months (n=260) and 12-months (n=252) follow-up. The data were analyzed using confirmatory factor analysis and a series of nested model comparisons in Mplus 3.0.

Results: The results indicated that the unidimensional measurement model and all of its parameters (e.g., factor loadings and item intercepts) were invariant over periods of 6 and 12 months.

Conclusion: We provide novel evidence that supports the unambiguous interpretation of scores from the MSWS-12 as a measure of change in walking impairment over time in a sample of persons with MS.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Cohort Studies
  • Disability Evaluation*
  • Disease Progression
  • Gait / physiology*
  • Gait Disorders, Neurologic / diagnosis*
  • Gait Disorders, Neurologic / etiology
  • Gait Disorders, Neurologic / physiopathology*
  • Humans
  • Longitudinal Studies
  • Mobility Limitation
  • Multiple Sclerosis, Relapsing-Remitting / complications
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology*
  • Observer Variation
  • Predictive Value of Tests
  • Prospective Studies
  • Severity of Illness Index
  • Surveys and Questionnaires / standards
  • Time Factors
  • Walking / physiology